104 related articles for article (PubMed ID: 34837894)
1. COVID-19 Vaccination and Cancer: Correspondence.
Mungmunpuntipantip R; Wiwanitkit V
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3417. PubMed ID: 34837894
[No Abstract] [Full Text] [Related]
2. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
Chung SH; Wener M; Bays AM; Rahbar H; Morishima C; Bryan AB; Fink SL; Cohen S; Mani NS; Chaudhary A; Gardner GC
Ann Rheum Dis; 2021 Oct; 80(10):e165. PubMed ID: 34340981
[No Abstract] [Full Text] [Related]
3. Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'.
Bugatti S; Balduzzi S; De Stefano L; Manzo A; Xoxi B; Bogliolo L; Monti S; Delvino P; Montecucco C
Ann Rheum Dis; 2021 Oct; 80(10):e156. PubMed ID: 33906858
[No Abstract] [Full Text] [Related]
4. Response to: 'Correspondence on 'EULAR December 2020 View points on SARS-CoV-2 vaccination in patients with RMDs'' by Bugatti
Bijlsma JWJ;
Ann Rheum Dis; 2021 Oct; 80(10):e157. PubMed ID: 33906856
[No Abstract] [Full Text] [Related]
5. Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff
Bonelli M; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):e163. PubMed ID: 34272251
[No Abstract] [Full Text] [Related]
6. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli
Benucci M; Damiani A; Infantino M; Manfredi M; Grossi V; Lari B; Li Gobbi F; Sarzi Puttini P
Ann Rheum Dis; 2021 Oct; 80(10):e166. PubMed ID: 34340979
[No Abstract] [Full Text] [Related]
7. Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
Bonelli M; Aletaha D
Ann Rheum Dis; 2021 Oct; 80(10):e167. PubMed ID: 34340982
[No Abstract] [Full Text] [Related]
8. COVID-19 Vaccination and Subclinical Axillary Lymphadenopathy on Mammogram: Correspondence.
Mungmunpuntipantip R; Wiwanitkit V
Acad Radiol; 2022 Apr; 29(4):633. PubMed ID: 35058134
[No Abstract] [Full Text] [Related]
9. COVID-19 vaccines and cancer patients: acceptance, attitudes and safety.
Matovina Brko G; Popovic M; Jovic M; Radic J; Bodlovic Kladar M; Nikolic I; Vidovic V; Kolarov Bjelobrk I; Kukic B; Salma S; Litavski J; Petrovic N; Vranjkovic B; Roganovic T; Ruzic M; Dugandzija T; Popovic L
J BUON; 2021; 26(5):2183-2190. PubMed ID: 34761633
[TBL] [Abstract][Full Text] [Related]
10. Transparency of the national government as key in promoting the rollout of COVID-19 vaccines.
Dela Cruz MDM; Mendoza AJM; Gueco GEA; Maghinang CJMP; Gopez JMW
J Public Health (Oxf); 2021 Jun; 43(2):e381-e382. PubMed ID: 33783541
[TBL] [Abstract][Full Text] [Related]
11. Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection, and change to single-dose vaccination.
Mungmunpuntipantip R; Wiwanitkit V
J Med Virol; 2021 Dec; 93(12):6474. PubMed ID: 34374991
[No Abstract] [Full Text] [Related]
12. Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients.
Heudel P; Favier B; Assaad S; Zrounba P; Blay JY
Ann Oncol; 2021 Nov; 32(11):1443-1444. PubMed ID: 34333128
[No Abstract] [Full Text] [Related]
13. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey.
Barrière J; Gal J; Hoch B; Cassuto O; Leysalle A; Chamorey E; Borchiellini D
Ann Oncol; 2021 May; 32(5):673-674. PubMed ID: 33529740
[No Abstract] [Full Text] [Related]
14. SARS-CoV-2 vaccination and phase 1 cancer clinical trials.
Yap TA; Siu LL; Calvo E; Lolkema MP; LoRusso PM; Soria JC; Plummer R; de Bono JS; Tabernero J; Banerji U
Lancet Oncol; 2021 Mar; 22(3):298-301. PubMed ID: 33571468
[No Abstract] [Full Text] [Related]
15. COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation.
Mattiuzzi C; Lippi G
J Infect Public Health; 2022 Apr; 15(4):395-396. PubMed ID: 35299063
[No Abstract] [Full Text] [Related]
16. [COVID-19 vaccination of cancer patients].
Brustugun OT; Heggelund L
Tidsskr Nor Laegeforen; 2021 Feb; 141(3):. PubMed ID: 33624982
[No Abstract] [Full Text] [Related]
17. Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
Guarino M; Cossiga V; Esposito I; Furno A; Morisco F
J Hepatol; 2022 Jan; 76(1):237-239. PubMed ID: 34358567
[No Abstract] [Full Text] [Related]
18. No-jab, no-job clause: ethical issues and legal impediments.
Corpuz JCG
J Public Health (Oxf); 2021 Jun; 43(2):e405-e406. PubMed ID: 33825879
[TBL] [Abstract][Full Text] [Related]
19. Correspondence on "hypermetabolic axillary lymph nodes in oncologic patients and COVID-19 vaccination".
Mungmunpuntipantip R; Wiwanitkit V
J Med Imaging Radiat Sci; 2022 Jun; 53(2):317. PubMed ID: 35317971
[No Abstract] [Full Text] [Related]
20. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
